medline.ch Onkologie Urologische Tumoren

	Differential impact of host-related factors on survival outcomes between IO+IO and IO+TKI in metastatic renal cell carcinoma: a multicenter retrospective study. Int J Clin Oncol Sugimoto K, Toyoda S, Inoki L, Mori K, Yanagisawa T, Tamura K, Nukaya T, Maenosono R, Morinaka H, Nishimura S, Bekku K, Komura K, Takahara K, Inamoto T, Azuma H, Fujita K, JK-FOOT study group. PMID: 42277542 [PubMed - as supplied by publisher]
	A lightweight ResNet50V2-ECA model for renal cell carcinoma grading: efficiency, calibration, and state-of-the-art performance. Sci Rep Alwateer M. PMID: 42277241 [PubMed - as supplied by publisher]
	How Will PSMAddition Impact the Management of Prostate Cancer? Eur Urol Focus Marulanda-Corzo V, Holmes AN, Giri VK, Osborne JR, Tagawa ST. PMID: 42276910 [PubMed - as supplied by publisher]
	Study Protocol of OLIGOPELVIS 2-GETUG P12: A Randomized Phase 3 Study Comparing Intermittent Androgen-deprivation Therapy with or Without Salvage High-dose Intensity-modulated Radiotherapy to Oligorecurrent Pelvic and Para-aortic Lymph Nodes in Patients with Biochemically Relapsing Prostate Cancer. Eur Urol Oncol Josset Q, Blanc-Lapierre A, Pigne G, Cartier L, Pasquier D, Ronchin P, Bera G, Hasbini A, Schipman B, Khalifa J, Sargos P, Quivrin M, Schick U, Mallet F, Laude C, Morand C, Loos G, Vaugier L, Zhou K, Mesgouez-Nebout N, Supiot S. PMID: 42276876 [PubMed - as supplied by publisher]
	Surgery or radiotherapy for early-stage cancer study protocol for an emulated target trial of radical radiotherapy versus radical cystectomy, with either following neoadjuvant chemotherapy, for organ-confined muscle-invasive bladder cancer. BMJ Open Kagenaar E, Lugo-Palacios DG, Bromley H, Aggarwal A, Hutchings A, O'Neill S, Rachet B, Cresswell J, Choudhury A, Grieve R. PMID: 42276804 [PubMed - in process]
	Urine IRF4/PENK/PXDN Methylation Signatures Enable Machine Learning-Driven Bladder Cancer Detection and Microenvironment Dissection. Technol Cancer Res Treat He Y, Xie W, Chen W, Dai S, Wang X, Zhao X, Lei S, Zhu W, Qian Y, Feng J, Gong Z, Li J, Yang P, Xu X, Fei W, Zhang D, Cao Y, Jin J. PMID: 42276585 [PubMed - indexed for MEDLINE]
	Molecular Mechanisms and Therapeutic Targets of Traditional Chinese Medicine Compounds in Renal Cell Carcinoma: A Comprehensive Narrative Review. J Ethnopharmacol Ye Z, Jia M, Tian X, Zhou B, Wang C, Lin H, Ma W, Dai R. PMID: 42276388 [PubMed - as supplied by publisher]
	UK prostate cancer screening trial to include more Black men. Lancet Oncol Gourd E. PMID: 42276089 [PubMed - as supplied by publisher]
	Complications after sentinel node biopsy and inguinal lymph node dissection in penile cancer: a Danish national cohort study. Int Urol Nephrol Mølsted J, Als AB, Jensen JB, Aagaard M, Jakobsen JK. PMID: 42274954 [PubMed - as supplied by publisher]
	Blue versus white light for transurethral resection of non-muscle invasive bladder cancer. Cochrane Database Syst Rev Maisch P, Hamidi Madani M, Koziarz A, Narayan VM, Kim MH, Dahm P. PMID: 42274003 [PubMed - in process]
	Current Status of PSMA-Targeted Agents Based on Small Molecules for Prostate Cancer in Preclinical Studies. Nucl Med Mol Imaging Muzammal A, Lee KC, Eom S. PMID: 42273657 [PubMed]
	Clinical Significance of the C-Reactive Protein-Triglyceride-Glucose Index in Cardiovascular Disease, Stroke, Cardiovascular-Kidney-Metabolic Syndrome, Cancer, Diabetes, and Osteoporosis: A Narrative Review. Int J Gen Med Yang S, Yao X, Chai J, Lu H, Tang W, Wu Z, He W, Xie Y. PMID: 42273529 [PubMed]
	Causal Association Between Gut Microbiota, Plasma Metabolites, and Prostate Cancer: Two-Step Mendelian Randomization Study. Dose Response Li J, Hou J, Liu H, Fan S, Wang Y, Liang P, Qin J, Gu P, Liu X, Wen X. PMID: 42273390 [PubMed]
	Evaluation of MRI-based risk models versus PI-RADS version 2.1 and arterial spin labeling perfusion imaging strategy for clinically significant prostate cancer. Quant Imaging Med Surg Wang W, Zheng X, Wang J, Liu N, Cai S, Xu Y. PMID: 42273125 [PubMed]
	Methodological considerations in a real-world study of first-line nivolumab plus ipilimumab for metastatic renal cell carcinoma. J Oncol Pharm Pract Das S, Dhyani A, Kumar R, Arora H. PMID: 42272406 [PubMed - as supplied by publisher]
	Integrating large language models into prostate cancer training: evidence from comparative benchmarking and a pilot randomized trial. BMC Med Educ Liu X, Chen M, Cai Y. PMID: 42271392 [PubMed - as supplied by publisher]
	A systematic review and meta-analysis of treatment-induced hypertension risks from androgen receptor pathway inhibitors in randomized controlled trials for prostate cancer. BMC Cancer Gong Q, Ge F, Chen T. PMID: 42271285 [PubMed - as supplied by publisher]
	Comparative efficacy and safety of carboplatin-based versus cisplatin-based chemotherapy in muscle-invasive and advanced bladder cancer: A systematic review and meta-analysis. Eur J Clin Pharmacol Liao J, Li X, Li G. PMID: 42271082 [PubMed - in process]
	Preoperative prediction of pathological pelvic lymph node metastasis in prostate cancer using an elastic net model integrating clinicopathologic and (68)Ga-PSMA PET/CT features: development and temporal validation. Sci Rep Chen Y, Gao L, Zheng Z, Feng P, Zhang C, Shi G, Li S, Hu J, Wang L, Wu B, Cao X. PMID: 42270733 [PubMed - as supplied by publisher]
	Comment on 'A study of oral metformin for the intravesical treatment of non-muscle-invasive bladder cancer'. BJU Int Urolagin D, Sowmya BA, Kavyashree MV. PMID: 42269719 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 178883

Seite 1 von 8945

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung